Progestin implants for female contraception.
Four different implants, in the form of capsules or covered rods, that release one of the synthetic progestins levonorgestrel, etonogestrel, Nestorone, or Elcometrine and nomegestrol acetate were reviewed. Biocompatible polymers or copolymers of polydimethyl/polymethylvinyl-siloxanes or ethylvinylacetate are used to hold the steroid crystals and to control the rate of release. Once inserted under the skin, these implants release the corresponding steroid continuously over prolonged periods, a process that can be readily interrupted by implant removal. During long-term use of the implant, the released steroid circulates in blood at a fairly stable level. The physical characteristics of the implants, including drug contents and rate of release, serum levels of the progestin during use, and the duration of their effective life are described. Total steroid loads vary in the range of 50 mg to 216 mg; average release rates are in the range of 30-100 ug/day, and effective lives from 6 months to 7 years.
Croxatt
Horacio B
HB
Instituto Chileno de Medicina Reproductiva, Santiago, Chile. hcroxatto@icmer.org
D001673:Biodegradation, Environmental; D003271:Contraceptive Agents, Female / Q000097:blood* / Q000737:chemistry / Q000493:pharmacokinetics; D004343:Drug Implants; D005260:Female; D006801:Humans; D045167:Progesterone Congeners / Q000097:blood* / Q000737:chemistry / Q000493:pharmacokinetics*
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D045167:Progesterone Congeners